Control of coronary vascular tone by nitric oxide.

A specific difference-spectrophotometric method was used to measure nitric oxide (NO) release into the coronary effluent perfusate of isolated, constant-flow-perfused guinea pig hearts. Authentic NO applied into the coronary circulation decreased vascular resistance dose dependently and enhanced coronary release of cyclic GMP (cGMP) fivefold. Increasing oxygen tension in aqueous solutions from 150 to 700 mm Hg decreased NO half-life (5.6 seconds) by 32%. During single passage through the intact coronary system, 86% of the infused NO was converted to nitrite ions. Oxidation of NO was more than 30 times faster within the heart than in aqueous solution. Endogenously formed NO was constantly released into the coronary effluent perfusate at a rate of 161 +/- 11 pmol/min. The NO scavenger oxyhemoglobin and methylene blue increased coronary resistance and decreased cGMP release (basal release, 342 +/- 4 fmol/min), whereas superoxide dismutase reduced coronary resistance. L-Arginine (10(-5) M) slightly decreased coronary perfusion pressure and enhanced release of cGMP. NG-Monomethyl L-arginine (10(-4) M) reduced basal release of NO and cGMP by 26% and 31%, respectively, paralleled by a coronary vasoconstriction. Bradykinin in the physiological range from 5 x 10(-11) M to 10(-7) M dilated coronary resistance vessels, which was paralleled by the release of NO and cGMP. Onset of NO release preceded onset of coronary vasodilation in all cases. Upon stimulation with bradykinin, amounts of endogenously formed NO were within the same range as the dose-response curves for exogenously applied NO both for changes in coronary resistance and cGMP release. Acetylcholine (10(-5) M), ATP (10(-5) M), and serotonin (10(-8) M) increased the rate of NO and cGMP release, resulting in coronary vasodilation. Our data suggest the following: 1) NO, the most rapidly acting vasodilator presently known, is metabolized within the heart mainly to nitrite and exhibits a half-life of only 0.1 second; 2) in the unstimulated heart, basal formation of NO may play an important role in setting the resting tone of coronary resistance vessels; 3) the kinetics and quantities of NO formation suggest that NO is causally involved in the bradykinin-induced coronary vasodilation; and 4) amounts of NO formed within the heart stimulated with ATP, acetylcholine, and serotonin are effective for vasodilation.

[1]  S Moncada,et al.  Role of endothelium-derived nitric oxide in the regulation of blood pressure. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[2]  B. Berkowitz,et al.  Anion exchange resins discriminate between nitric oxide and EDRF. , 1987, European journal of pharmacology.

[3]  Peter Griess,et al.  Bemerkungen zu der Abhandlung der HH. Weselsky und Benedikt „Ueber einige Azoverbindungen” , 1879 .

[4]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[5]  J. Hibbs,et al.  Macrophage cytotoxicity: role for L-arginine deiminase and imino nitrogen oxidation to nitrite. , 1987, Science.

[6]  W. Dole,et al.  Acute Hypertension Selectively Potentiates Constrictor Responses of Large Coronary Arteries to Serotonin by Altering Endothelial Function In Vivo , 1987, Circulation research.

[7]  M. Marletta,et al.  Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. , 1988, Biochemistry.

[8]  M. Doyle,et al.  Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. , 1981, Journal of inorganic biochemistry.

[9]  S. Moncada,et al.  Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor , 1986, Nature.

[10]  H. Bunn,et al.  Hemoglobin: Molecular, Genetic and Clinical Aspects , 1984 .

[11]  R. Furchgott,et al.  Role of endothelial cells in relaxation of isolated arteries by bradykinin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D. Regoli,et al.  Pharmacology of bradykinin and related kinins. , 1980, Advances in experimental medicine and biology.

[13]  M. Feelisch,et al.  Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase. , 1987, European journal of pharmacology.

[14]  E. Feigl,et al.  Coronary physiology. , 1983, Physiological reviews.

[15]  D. Stewart,et al.  Reversal of acetylcholine-induced coronary resistance vessel dilation by hemoglobin. , 1987, European journal of pharmacology.

[16]  F. Murad,et al.  Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tissue preparations. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[17]  E. D. Di Iorio,et al.  Preparation of derivatives of ferrous and ferric hemoglobin. , 1981, Methods in enzymology.

[18]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[19]  S. Moncada,et al.  L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. , 1988, Biochemical and biophysical research communications.

[20]  S. Marklund,et al.  Heparin-induced release of extracellular superoxide dismutase to human blood plasma. , 1987, The Biochemical journal.

[21]  D. Edwards,et al.  EDRF coordinates the behaviour of vascular resistance vessels , 1987, Nature.

[22]  J. L. Gordon.  Extracellular ATP: effects, sources and fate. , 1986, The Biochemical journal.

[23]  L. Ignarro,et al.  Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.

[24]  J. Schrader,et al.  Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cells. , 1988, Biochemical and biophysical research communications.

[25]  T. Slater,et al.  Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. , 1987, Circulation research.

[26]  L. Ignarro,et al.  Basic Polyamino Acids Rich in Arginine, Lysine, or Ornithine Cause Both Enhancement of and Refractoriness to Formation of Endothelium‐Derived Nitric Oxide in Pulmonary Artery and Vein , 1989, Circulation research.

[27]  J. T. Shepherd,et al.  Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets. , 1983, Science.

[28]  R M Rapoport,et al.  Endothelium-dependent and nitrovasodilator-induced relaxation of vascular smooth muscle: role of cyclic GMP. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[29]  R. Busse,et al.  Hyperpolarization and increased free calcium in acetylcholine-stimulated endothelial cells. , 1988, The American journal of physiology.

[30]  D. Kunze,et al.  Bradykinin‐Induced Increases in Cytosolic Calcium and Ionic Currents in Cultured Bovine Aortic Endothelial Cells , 1987, Circulation research.

[31]  K. Krohn,et al.  Nitrogen-13-labeled nitrite and nitrate: distribution and metabolism after intratracheal administration. , 1981, Science.

[32]  W. Halpern,et al.  Endothelium-dependent and endothelium-independent vasodilation in resistance arteries from hypertensive rats. , 1988, Hypertension.

[33]  L. Ignarro,et al.  Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical , 1987, Circulation research.

[34]  R. Busse,et al.  Selective inhibition of endothelium-dependent dilation in resistance-sized vessels in vivo. , 1987, The American journal of physiology.

[35]  Ernesto E. Di Iorio,et al.  [4] Preparation of derivatives of ferrous and ferric hemoglobin , 1981 .

[36]  B. Altura,et al.  Acetylcholine and bradykinin relax intrapulmonary arteries by acting on endothelial cells: role in lung vascular diseases. , 1981, Science.

[37]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[38]  R. C. Dennis,et al.  Coronary constrictor effect of stroma-free hemoglobin solutions. , 1986, The American journal of physiology.

[39]  K. Imaizumi,et al.  Mechanism of autocatalytic oxidation of oxyhemoglobin by nitrite. An intermediate detected by electron spin resonance. , 1982, Biochimica et biophysica acta.

[40]  Louette R. Johnson Lutjens.  Research , 2006 .

[41]  S. Moncada,et al.  Acetylcholine induces vasodilatation in the rabbit isolated heart through the release of nitric oxide, the endogenous nitrovasodilator , 1988, British journal of pharmacology.

[42]  T. Eskes,et al.  Bradykinin and cardiovascular system: estimation of half-life. , 1962, The American journal of physiology.

[43]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[44]  R. Schnaar,et al.  Response of large and small coronary arteries to nitroglycerin, NaNO 2 , and adenosine. , 1972, The American journal of physiology.

[45]  M. Feelisch,et al.  Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. , 1987, European journal of pharmacology.

[46]  H. Limpricht.  Ueber einige Azoverbindungen , 1891 .

[47]  W. K. Metcalf,et al.  The kinetic differences between sodium nitrite, amyl nitrite and nitroglycerin oxidation of hemoglobin. , 1986, Histology and histopathology.

[48]  J. Schrader,et al.  Transendothelial Transport and Metabolism of Adenosine and Inosine in the Intact Rat Aorta , 1989, Circulation research.

[49]  B. Berkowitz,et al.  Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle. , 1987, The Journal of pharmacology and experimental therapeutics.

[50]  W. Wienen,et al.  Intra- and extracellular markers in interstitial transudate of perfused rat hearts. , 1988, The American journal of physiology.

[51]  R. Furchgott,et al.  Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. , 1985, The Journal of pharmacology and experimental therapeutics.

[52]  J. Pearson,et al.  Kinetics of adenine nucleotide catabolism in coronary circulation of rats. , 1989, The American journal of physiology.

[53]  P. Ganz,et al.  Reversible microcarrier-mediated junctional communication between endothelial and smooth muscle cell monolayers: an in vitro model of vascular cell interactions. , 1985, Laboratory investigation; a journal of technical methods and pathology.

[54]  R. Furchgott,et al.  Evidence for endothelium-dependent vasodilation of resistance vessels by acetylcholine. , 1987, Blood vessels.

[55]  J. Schrader,et al.  Nitric oxide release from the isolated guinea pig heart. , 1988, European journal of pharmacology.

[56]  U. Förstermann,et al.  Response of Human Coronary Arteries to Aggregating Platelets: Importance of Endothelium‐Derived Relaxing Factor and Prostanoids , 1988, Circulation research.

[57]  R. Furchgott,et al.  Depression of contractile responses in rat aorta by spontaneously released endothelium-derived relaxing factor. , 1986, The Journal of pharmacology and experimental therapeutics.

[58]  F. DeRubertis,et al.  Restoration of the responsiveness of purified guanylate cyclase to nitrosoguanidine, nitric oxide, and related activators by heme and hemeproteins. Evidence for involvement of the paramagnetic nitrosyl-heme complex in enzyme activation. , 1978, The Journal of biological chemistry.

[59]  K. Kroll,et al.  Release of Adenosine and Cyclic AMP From Coronary Endothelium in Isolated Guinea Pig Hearts: Relation to Coronary Flow , 1987, Circulation research.

[60]  L. Ignarro,et al.  The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. , 1985, Annual review of pharmacology and toxicology.

[61]  W. Caughey,et al.  The mechanisms of hemoglobin autoxidation. Evidence for proton-assisted nucleophilic displacement of superoxide by anions. , 1974, Biochemical and biophysical research communications.

[62]  K. Komori,et al.  Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. , 1988, The American journal of physiology.